Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (481-490 of 612) with videos related to

Pageof 62
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE StudyHoward S Hochster, Lowell L Hart, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2016
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapyAraz Marachelian, Ami Desai, Frank Balis, et al.
Cell Reports|May 20, 2014
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastomaChristopher J Mariani, Aparna Vasanthakumar, Jozef Madzo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 3, 2004
International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactionsT J Bos, S L Cohn, H K Kleinman, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety UpdateVicky Makker, Carol Aghajanian, Allen L Cohn, et al.
Annals of Surgery|September 12, 2012
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group studyJed G Nuchtern, Wendy B London, Carol E Barnewolt, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
The impact of human immunodeficiency virus infection on drug-resistant tuberculosisF M Gordin, E T Nelson, J P Matts, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG projectPaola Angelini, Wendy B London, Susan L Cohn, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|February 14, 2020
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020Timothy R Sterling, Gibril Njie, Dominik Zenner, et al.
Pageof 62

Showing results (481-490 of 612) with videos related to

Sort By:
Pageof 62
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE StudyHoward S Hochster, Lowell L Hart, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2016
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapyAraz Marachelian, Ami Desai, Frank Balis, et al.
Cell Reports|May 20, 2014
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastomaChristopher J Mariani, Aparna Vasanthakumar, Jozef Madzo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 3, 2004
International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactionsT J Bos, S L Cohn, H K Kleinman, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety UpdateVicky Makker, Carol Aghajanian, Allen L Cohn, et al.
Annals of Surgery|September 12, 2012
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group studyJed G Nuchtern, Wendy B London, Carol E Barnewolt, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
The impact of human immunodeficiency virus infection on drug-resistant tuberculosisF M Gordin, E T Nelson, J P Matts, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG projectPaola Angelini, Wendy B London, Susan L Cohn, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|February 14, 2020
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020Timothy R Sterling, Gibril Njie, Dominik Zenner, et al.
Pageof 62